Shun Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shun Duan has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- Fu-Jian Xu
State Key Laboratory of Chemical Resource Engineering, Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education), Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China
39 shared publications - Xiaokang Ding
Key Laboratory of Biomedical Materials of Natural Macromolecules Ministry of Education, Beijing University of Chemical Technology Beijing P. R. China
15 shared publications - Bingran Yu
Beijing University of Chemical Technology
11 shared publications - Nana Zhao
State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, China
10 shared publications Ruonan Wu
10 shared publicationsXiaoping Yang
Beijing University of Chemical Technology
10 shared publications
Latest Publications
- 31 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (36) , 39377-39378
Correction to “Bioinspired Amine-Guided Polyphenol Coatings for Selective Bacterial Disruption and Osseointegration on Orthopedic Implants”
- 31 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (36) , 39377-39378
Correction to “Bioinspired Amine-Guided Polyphenol Coatings for Selective Bacterial Disruption and Osseointegration on Orthopedic Implants”
- 20 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Dual-Action Cationic Nanoparticle Eye Drops Synergistically Disrupt the Pathological Cycle of Dry Eye Disease via ROS-Scavenging and Inflammation Inhibition
Dry eye disease (DED) is an increasingly prevalent ocular surface disorder that causes discomfort and, in severe cases, visual impairment. A central feature of DED is a self-perpetuating oxidative stress–inflammation cycle, in which excessive reactive oxygen species (ROS) production initiates and sustains inflammatory injury. Treatments directed only at inflammation may therefore provide incomplete control. Here, we developed self-assembled PGED-TEMPO-2/fibronectin (FN) nanoparticle eye drops comprising a ROS-scavenging cationic polymer and an extracellular matrix protein with reported immunomodulatory activity. The cationic surface may favor interaction with negatively charged corneal mucins, thereby contributing to prolonged ocular surface retention. In vitro and in vivo, PGED-TEMPO-2/FN reduced ROS accumulation, preserved mitochondrial membrane potential, lowered pro-inflammatory cytokine expression, modulated macrophage polarization, and decreased apoptosis. In a benzalkonium chloride-induced mouse model of DED, the formulation reduced ocular surface inflammation, promoted corneal epithelial repair, and produced greater mean improvements than cyclosporine under the tested regimen. Thus, PGED-TEMPO-2/FN integrates antioxidant activity, protein delivery, and ocular retention in a single topical platform for DED treatment.
- 20 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Dual-Action Cationic Nanoparticle Eye Drops Synergistically Disrupt the Pathological Cycle of Dry Eye Disease via ROS-Scavenging and Inflammation Inhibition
Dry eye disease (DED) is an increasingly prevalent ocular surface disorder that causes discomfort and, in severe cases, visual impairment. A central feature of DED is a self-perpetuating oxidative stress–inflammation cycle, in which excessive reactive oxygen species (ROS) production initiates and sustains inflammatory injury. Treatments directed only at inflammation may therefore provide incomplete control. Here, we developed self-assembled PGED-TEMPO-2/fibronectin (FN) nanoparticle eye drops comprising a ROS-scavenging cationic polymer and an extracellular matrix protein with reported immunomodulatory activity. The cationic surface may favor interaction with negatively charged corneal mucins, thereby contributing to prolonged ocular surface retention. In vitro and in vivo, PGED-TEMPO-2/FN reduced ROS accumulation, preserved mitochondrial membrane potential, lowered pro-inflammatory cytokine expression, modulated macrophage polarization, and decreased apoptosis. In a benzalkonium chloride-induced mouse model of DED, the formulation reduced ocular surface inflammation, promoted corneal epithelial repair, and produced greater mean improvements than cyclosporine under the tested regimen. Thus, PGED-TEMPO-2/FN integrates antioxidant activity, protein delivery, and ocular retention in a single topical platform for DED treatment.
- 15 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Minimizing Implant Rejections through Low-Inflammatory and Immune-Regulatory Biointerfaces
Implantable materials are continuously facing implant rejection due to foreign body responses (FBR) and insufficient tissue integration. Herein, we develop a versatile surface modification strategy based on hyaluronic acid (HA) to construct low-inflammatory and immune-regulatory biointerfaces that are able to inhibit the formation of FBR associated fibrotic capsules and promote the tissue integration of the implanted medical devices. The HA-based biointerfaces are able to establish surface-mediated immune responses and regulate immuno-microenvironments ex vivo and in vivo, for which bioinformatics analyses reveal the immuno-regulation mechanisms. With the modification of HA, histological analysis reveals a noteworthy reduction in capsule thickness. Furthermore, we demonstrate improved osseointegration when Arg-Gly-Asp (RGD) modified HA is functionalized onto titanium implants. This work presents an approach for developing biointerfaces of implanted medical devices to tackle implant rejection.
- 15 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Minimizing Implant Rejections through Low-Inflammatory and Immune-Regulatory Biointerfaces
Implantable materials are continuously facing implant rejection due to foreign body responses (FBR) and insufficient tissue integration. Herein, we develop a versatile surface modification strategy based on hyaluronic acid (HA) to construct low-inflammatory and immune-regulatory biointerfaces that are able to inhibit the formation of FBR associated fibrotic capsules and promote the tissue integration of the implanted medical devices. The HA-based biointerfaces are able to establish surface-mediated immune responses and regulate immuno-microenvironments ex vivo and in vivo, for which bioinformatics analyses reveal the immuno-regulation mechanisms. With the modification of HA, histological analysis reveals a noteworthy reduction in capsule thickness. Furthermore, we demonstrate improved osseointegration when Arg-Gly-Asp (RGD) modified HA is functionalized onto titanium implants. This work presents an approach for developing biointerfaces of implanted medical devices to tackle implant rejection.
- 27 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (22) , 31003-31014
Silicon(IV) Phthalocyanine-Functionalized Hyaluronic Acid for Photodynamic Eradication of Methicillin-Resistant Staphylococcus aureus Infections
Methicillin-resistant Staphylococcus aureus (MRSA) poses a severe threat in bacterial wound infections, driving the need for effective nonantibiotic strategies. Antimicrobial photodynamic therapy (aPDT) using phthalocyanines (Pcs) as photosensitizers is promising but often hampered by their poor aqueous solubility and aggregation-induced quenching. Herein, we report the design and synthesis of a highly water-soluble photosensitizer (PcSi-HA) by the axial conjugation of silicon(IV) phthalocyanine (PcSi) molecules to the polymer backbone of hyaluronic acid (HA). The bulky and hydrophilic HA chain effectively suppresses the detrimental π-π stacking of PcSi molecules, significantly enhancing both solubility and reactive oxygen species (ROS) generation upon 650 nm light irradiation. PcSi-HA achieved 99% antibacterial efficacy against both S. aureus and MRSA at an ultralow concentration of 2 μg/mL, whereas negligible antibacterial activity was observed in the absence of irradiation. Among the ROS generated by PcSi-HA, the mechanistic studies reveal that hydrogen peroxide (H2O2) serves as the dominant bactericidal species. To facilitate practical application, PcSi-HA was physically loaded onto a polyimide (PI) nanofibrous membrane (prepared via electrospinning of a poly(amic acid) (PAA) precursor followed by thermal imidization) to fabricate a flexible photodynamic wound dressing (PI-PcSi). In a murine model of MRSA-infected wounds, the PI-PcSi dressing, under light irradiation, effectively eliminated bacteria and accelerated wound healing by promoting collagen deposition. This work presents a facile strategy for developing advanced phthalocyanine-based biomaterials via polysaccharide functionalization, offering a potent and biocompatible platform for combating drug-resistant bacterial infections.
- 27 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (22) , 31003-31014
Silicon(IV) Phthalocyanine-Functionalized Hyaluronic Acid for Photodynamic Eradication of Methicillin-Resistant Staphylococcus aureus Infections
Methicillin-resistant Staphylococcus aureus (MRSA) poses a severe threat in bacterial wound infections, driving the need for effective nonantibiotic strategies. Antimicrobial photodynamic therapy (aPDT) using phthalocyanines (Pcs) as photosensitizers is promising but often hampered by their poor aqueous solubility and aggregation-induced quenching. Herein, we report the design and synthesis of a highly water-soluble photosensitizer (PcSi-HA) by the axial conjugation of silicon(IV) phthalocyanine (PcSi) molecules to the polymer backbone of hyaluronic acid (HA). The bulky and hydrophilic HA chain effectively suppresses the detrimental π-π stacking of PcSi molecules, significantly enhancing both solubility and reactive oxygen species (ROS) generation upon 650 nm light irradiation. PcSi-HA achieved 99% antibacterial efficacy against both S. aureus and MRSA at an ultralow concentration of 2 μg/mL, whereas negligible antibacterial activity was observed in the absence of irradiation. Among the ROS generated by PcSi-HA, the mechanistic studies reveal that hydrogen peroxide (H2O2) serves as the dominant bactericidal species. To facilitate practical application, PcSi-HA was physically loaded onto a polyimide (PI) nanofibrous membrane (prepared via electrospinning of a poly(amic acid) (PAA) precursor followed by thermal imidization) to fabricate a flexible photodynamic wound dressing (PI-PcSi). In a murine model of MRSA-infected wounds, the PI-PcSi dressing, under light irradiation, effectively eliminated bacteria and accelerated wound healing by promoting collagen deposition. This work presents a facile strategy for developing advanced phthalocyanine-based biomaterials via polysaccharide functionalization, offering a potent and biocompatible platform for combating drug-resistant bacterial infections.
- 1 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (14) , 20209-20227
Combined Antibacterial-Osteogenic Modulation of Orthopedic Implants through Thermo-Induced Bioinspired Interfacial Activation
Periprosthetic joint infection (PJI) and aseptic loosening remain the leading causes of arthroplasty failure, yet existing antimicrobial coatings suffer from limited durability and poor osteointegration. Here, we report a thermo-bioactivated nanohybrid coating (Ti-AQR) that integrates photothermal conversion with bioactive functionalities to achieve combined antibacterial and osteogenic modulation. Ti-AQR could provide stable and durable near-infrared (NIR)-induced mild photothermal performance by Au NRs, a typical photothermal agent, while a chitosan derivative (QTR) with quaternary ammonium groups and RGD motifs delivered both bactericidal and osteoinductive functions, which were promoted by the mild photothermal effect. Under mild photothermal stimulation, the effect of bacterial membrane disruption by the alkyl chains in quaternary ammonium groups was amplified by mild heat, lowering the temperature threshold for effective bacterial killing. Concurrently, mesenchymal stem cell adhesion, osteogenic differentiation, and matrix mineralization were enhanced by the RGD motifs of Ti-AQR combined with subhyperthermic heat. Ti-AQR eradicated >99.9% of Staphylococcus aureus and >97% of Escherichia coli through combined heat-assisted contact killing, while markedly upregulating osteogenic markers, alkaline phosphatase activity, and calcification. Mechanistically, the mild photothermal effect of Ti-AQR activated the MAPK pathway and upregulated heat shock protein-related genes. In animal experiments, Ti-AQR implants simultaneously prevented early-stage infection and significantly improved bone-implant integration. This thermo-induced interfacial synergy establishes a versatile strategy for functionalization of orthopedic implants, offering dynamic, controllable, and biocompatible solutions against both infection and loosening.
- 1 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (14) , 20209-20227
Combined Antibacterial-Osteogenic Modulation of Orthopedic Implants through Thermo-Induced Bioinspired Interfacial Activation
Periprosthetic joint infection (PJI) and aseptic loosening remain the leading causes of arthroplasty failure, yet existing antimicrobial coatings suffer from limited durability and poor osteointegration. Here, we report a thermo-bioactivated nanohybrid coating (Ti-AQR) that integrates photothermal conversion with bioactive functionalities to achieve combined antibacterial and osteogenic modulation. Ti-AQR could provide stable and durable near-infrared (NIR)-induced mild photothermal performance by Au NRs, a typical photothermal agent, while a chitosan derivative (QTR) with quaternary ammonium groups and RGD motifs delivered both bactericidal and osteoinductive functions, which were promoted by the mild photothermal effect. Under mild photothermal stimulation, the effect of bacterial membrane disruption by the alkyl chains in quaternary ammonium groups was amplified by mild heat, lowering the temperature threshold for effective bacterial killing. Concurrently, mesenchymal stem cell adhesion, osteogenic differentiation, and matrix mineralization were enhanced by the RGD motifs of Ti-AQR combined with subhyperthermic heat. Ti-AQR eradicated >99.9% of Staphylococcus aureus and >97% of Escherichia coli through combined heat-assisted contact killing, while markedly upregulating osteogenic markers, alkaline phosphatase activity, and calcification. Mechanistically, the mild photothermal effect of Ti-AQR activated the MAPK pathway and upregulated heat shock protein-related genes. In animal experiments, Ti-AQR implants simultaneously prevented early-stage infection and significantly improved bone-implant integration. This thermo-induced interfacial synergy establishes a versatile strategy for functionalization of orthopedic implants, offering dynamic, controllable, and biocompatible solutions against both infection and loosening.
- 30 March 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
Polymeric quaternary ammonium enabled contact-active, bulk-stable and biocompatible antibacterial catheters without leaching-dependent antimicrobial additives
This work reports a non-leaching antibacterial TPU strategy via quaternized polyethyleneimine (QPEI). The catheters show broad-spectrum antibacterial activity, good biocompatibility, and effective in vitro and in vivo anti-infection performance.
- 30 March 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
Polymeric quaternary ammonium enabled contact-active, bulk-stable and biocompatible antibacterial catheters without leaching-dependent antimicrobial additives
This work reports a non-leaching antibacterial TPU strategy via quaternized polyethyleneimine (QPEI). The catheters show broad-spectrum antibacterial activity, good biocompatibility, and effective in vitro and in vivo anti-infection performance.
- 20 February 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (8) , 7382-7383
Correction to “Well-Defined Gold Nanorod/Polymer Hybrid Coating with Inherent Antifouling and Photothermal Bactericidal Properties for Treating Infected Hernia”
- 20 February 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (8) , 7382-7383
Correction to “Well-Defined Gold Nanorod/Polymer Hybrid Coating with Inherent Antifouling and Photothermal Bactericidal Properties for Treating Infected Hernia”
- 4 January 2026
- Published by Springer Nature in Science China Materials
- Vol. 69 (4) , 2237-2249
Microcrystallization-gelation enabled mechanocompatible and antibacterial hydrogels for cartilage repair
- 4 January 2026
- Published by Springer Nature in Science China Materials
- Vol. 69 (4) , 2237-2249
Microcrystallization-gelation enabled mechanocompatible and antibacterial hydrogels for cartilage repair
- 2 July 2025
- Published by Elsevier in Biomaterials
- Vol. 324, 123531
A heterogeneous hydrogel patch with mechanical activity and bioactivity for chronic diabetic wound healing
- 2 July 2025
- Published by Elsevier in Biomaterials
- Vol. 324, 123531
A heterogeneous hydrogel patch with mechanical activity and bioactivity for chronic diabetic wound healing
- Top Cited Papers
- 1 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (37) , e2506113
Surface‐Engineered Orthopedic Implant to Break the Antimicrobial‐Osteogenic Paradox at Biointerfaces in the “Race for the Surface”
Implant‐associated infections and compromised osseointegration pose a dual threat to bone implants due to the biological conflict between microbial invasion and host cell colonization. However, conventional contact‐killing antimicrobial coatings may negatively affect the viability of mammalian cells, limiting their further application. Here, a surface modification strategy is proposed to help mammalian cells to win the “race for the surface” on the material‐tissue interfaces. Through polyphenol‐amine‐mediated covalent modification, quaternary ammonium groups (bactericidal agents) and phosphate groups (promoting bone‐regeneration factors) are spatially organized on titanium (Ti) surfaces to regulate the surface chemical characteristics of dental implants. The surface‐engineered implants (Ti‐AQs) exhibited balanced antibacterial and biocompatible properties. The optimized Ti‐AQ‐2 coating eradicated >99% of Staphylococcus aureus ( S. aureus) and Escherichia coli ( E. coli) via destruction of disrupted bacterial membranes through metabolic interference, and simultaneously promoted adhesion, proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through Ca 2+ ‐mediated signaling pathways. Moreover, Ti‐AQs can drive immunomodulation biased macrophages toward pro‐repair M2 polarization. In vivo evaluations in an implant‐associated infection modal confirmed that Ti‐AQ‐2 inhibited infection at the early stage and enhanced bone‐implant integration at the late stage. This work presents a facile strategy to regulate the surface performances for developing of antibacterial implants with high biocompatibility and bioactivity.
- 1 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (37) , e2506113
Top Cited PapersSurface‐Engineered Orthopedic Implant to Break the Antimicrobial‐Osteogenic Paradox at Biointerfaces in the “Race for the Surface”
Implant‐associated infections and compromised osseointegration pose a dual threat to bone implants due to the biological conflict between microbial invasion and host cell colonization. However, conventional contact‐killing antimicrobial coatings may negatively affect the viability of mammalian cells, limiting their further application. Here, a surface modification strategy is proposed to help mammalian cells to win the “race for the surface” on the material‐tissue interfaces. Through polyphenol‐amine‐mediated covalent modification, quaternary ammonium groups (bactericidal agents) and phosphate groups (promoting bone‐regeneration factors) are spatially organized on titanium (Ti) surfaces to regulate the surface chemical characteristics of dental implants. The surface‐engineered implants (Ti‐AQs) exhibited balanced antibacterial and biocompatible properties. The optimized Ti‐AQ‐2 coating eradicated >99% of Staphylococcus aureus ( S. aureus) and Escherichia coli ( E. coli) via destruction of disrupted bacterial membranes through metabolic interference, and simultaneously promoted adhesion, proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through Ca 2+ ‐mediated signaling pathways. Moreover, Ti‐AQs can drive immunomodulation biased macrophages toward pro‐repair M2 polarization. In vivo evaluations in an implant‐associated infection modal confirmed that Ti‐AQ‐2 inhibited infection at the early stage and enhanced bone‐implant integration at the late stage. This work presents a facile strategy to regulate the surface performances for developing of antibacterial implants with high biocompatibility and bioactivity.